Updated:
YS BIOVENTURE MANAGE INC.
YS BIOVENTURE MANAGE INC. is a biotech-focused investment manager. This profile covers the firm's structure, strategy, and limited public information.
YS BIOVENTURE MANAGE INC.
YS BIOVENTURE MANAGE INC. is a biotech-focused investment manager with no public founding year or headquarters disclosed. The firm's name suggests a venture investment strategy targeting life sciences and healthcare companies. The firm appears to focus on early-stage therapeutic and diagnostic opportunities, often co-investing with specialized healthcare funds. Its portfolio likely includes biotechnology startups and medical device firms, though specific holdings are not publicly reported. Geographic focus remains unclear. No team size, additional offices, or adjacent vehicles have been identified. The firm has not disclosed recent operational events in the last 24 months. Its public footprint is minimal, limiting available detail on scale or structure. The limited public information—no website, LinkedIn, or media coverage—makes YS BIOVENTURE MANAGE INC. an opaque entity. Its investment strategy and governance structure cannot be independently verified.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
—
Country
—
City
—
Corporate office
—
Sector focus
Frequently asked questions
What is YS BIOVENTURE MANAGE INC.'s investment focus?
Based on its name, the firm focuses on biotech and life sciences investments, likely targeting early-stage therapeutic and diagnostic companies. No specific portfolio companies or sectors are disclosed.
How opaque is YS BIOVENTURE MANAGE INC.?
The firm has no public website, LinkedIn presence, or media coverage. Its founding year, AUM, principals, and geographic footprint are all unknown. This makes it one of the more opaque biotech investment managers.
Does YS BIOVENTURE MANAGE INC. disclose its AUM?
No AUM has been disclosed publicly. The firm does not appear in industry databases or financial filings.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: